Literature DB >> 18751890

Abeta(25-35) attenuated SREBP level in nuclear extracts of serum-deprived human neuroblastoma cells.

Pelin Kelicen1, Mehtap Cincioğlu, Fatih Hizli, Agneta Nordberg.   

Abstract

Disturbance in cholesterol homeostasis appears to be an important factor in the pathogenesis of neurodegenerative disorders. The aim of the present study was to investigate sterol regulatory element binding protein (SREBP) levels in the nuclear extracts of human neuroblastoma cells and the possible interaction of beta-amyloid peptide (Abeta) and cholesterol with this transcription factor. In this study, cultured human neuroblastoma cells (SHSY-5Y) were incubated in serum-deprived media in the presence or absence of Abeta((25-35)) (1 microM) or cholesterol (300 microM) for 24 h. Nuclear extracts were subjected to SDS-PAGE, and SREBP cleavage product (68 kDa) was detected by immunoblotting. SREBP levels were elevated in the cells incubated 24 h in serum-deprived experimental media and were attenuated by Abeta or cholesterol-supplementation. It is likely that the ability of Abeta to release cholesterol into the medium and downregulate SREBP is due to a feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751890     DOI: 10.1007/s11064-008-9832-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

Review 1.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.

Authors:  H Shimano
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

Review 2.  Four cholesterol-sensing proteins.

Authors:  Y Lange; T L Steck
Journal:  Curr Opin Struct Biol       Date:  1998-08       Impact factor: 6.809

3.  Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice.

Authors:  N Sawamura; J S Gong; W S Garver; R A Heidenreich; H Ninomiya; K Ohno; K Yanagisawa; M Michikawa
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

4.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

Authors:  S Bodovitz; W L Klein
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

5.  Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  J Neuropathol Exp Neurol       Date:  1990-05       Impact factor: 3.685

6.  A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.

Authors:  M Michikawa; J S Gong; Q W Fan; N Sawamura; K Yanagisawa
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 7.  Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

Authors:  Kumar Sambamurti; Ann-Charlotte Granholm; Mark S Kindy; Narayan R Bhat; Nigel H Greig; Debomoy K Lahiri; Jacobo E Mintzer
Journal:  Curr Drug Targets       Date:  2004-08       Impact factor: 3.465

8.  Cholesterol, synaptic function and Alzheimer's disease.

Authors:  Alexei R Koudinov; Natalia V Koudinova
Journal:  Pharmacopsychiatry       Date:  2003-09       Impact factor: 5.788

9.  Amyloid beta-protein affects cholesterol metabolism in cultured neurons: implications for pivotal role of cholesterol in the amyloid cascade.

Authors:  Jian-Sheng Gong; Naoya Sawamura; Kun Zou; Juro Sakai; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Neurosci Res       Date:  2002-11-01       Impact factor: 4.164

10.  Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism.

Authors:  Andrew J Brown; Liping Sun; Jamison D Feramisco; Michael S Brown; Joseph L Goldstein
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.